Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone Hexacetonide Dosing for Knee Synovitis
NCT02437461Phase 4Unknown
- Sponsor
- Uppsala University
- Start
- Apr 2015
- Primary completion
- Sep 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone hexacetonide in synovitis, sponsored by Uppsala University. Status: unknown.
02
Drugs
triamcinolone hexacetonide
03
Conditions
synovitis
Beyond the preview
Go deeper on NCT02437461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02437461.